ACADS Gene Acyl-CoA Short-Chain Dehydrogenase Deficiency Genetic Test
At DNA Labs UAE, we offer the ACADS Gene Acyl-CoA short-chain dehydrogenase deficiency genetic test to help diagnose and understand this metabolic disorder. This test is performed using NGS (Next-Generation Sequencing) technology, providing a comprehensive evaluation of genetic variations.
Test Details
The ACADS gene is responsible for encoding the enzyme acyl-CoA dehydrogenase, which is involved in the breakdown of fatty acids for energy production. Mutations in this gene can lead to acyl-CoA short-chain dehydrogenase deficiency, an autosomal recessive disorder affecting the metabolism of short-chain fatty acids.
Common symptoms of acyl-CoA short-chain dehydrogenase deficiency include muscle weakness, lethargy, poor feeding, and developmental delay. In severe cases, it can result in life-threatening episodes of metabolic crisis, such as hypoglycemia and liver dysfunction.
Our NGS genetic testing method allows us to identify specific mutations in the ACADS gene that may be causing the condition. By accurately diagnosing the underlying cause, healthcare professionals can provide appropriate treatment and guidance.
Test Components and Price
The ACADS Gene Acyl-CoA short-chain dehydrogenase deficiency genetic test is priced at 4400.0 AED. The test requires a blood sample for analysis.
Report Delivery and Method
After the sample is collected, the report will be delivered within 3 to 4 weeks. Our NGS technology ensures a thorough and accurate analysis of the ACADS gene.
Referring Doctor and Test Department
This test is recommended by general physicians and falls under the Genetics department at DNA Labs UAE.
Pre-Test Information
Prior to undergoing the ACADS Gene Acyl-CoA short-chain dehydrogenase deficiency genetic test, it is important to provide a clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by the condition. This information aids in the interpretation of test results.
Benefits of NGS Genetic Testing
NGS genetic testing offers numerous benefits for individuals with suspected acyl-CoA short-chain dehydrogenase deficiency. It can guide treatment decisions, provide information about the risk of passing on the condition to future children, and offer insights into potential complications or associated conditions.
It is crucial to note that genetic testing should only be performed and interpreted by qualified healthcare professionals, such as genetic counselors or medical geneticists. These professionals can provide appropriate counseling and guidance based on the test results.
Choose DNA Labs UAE for reliable and accurate genetic testing. Contact us today to schedule your ACADS Gene Acyl-CoA short-chain dehydrogenase deficiency genetic test.
| Test Name | ACADS Gene Acyl-CoA short-chain dehydrogenase deficiency Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Metabolic Disorders |
| Doctor | General Physician |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for ACADS Gene Acyl-CoA short-chain dehydrogenase deficiency NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Acyl-CoA short-chain dehydrogenase deficiency |
| Test Details | The ACADS gene is responsible for encoding the enzyme acyl-CoA dehydrogenase, which plays a role in the breakdown of fatty acids for energy production. Mutations in this gene can lead to a condition called acyl-CoA short-chain dehydrogenase deficiency. Acyl-CoA short-chain dehydrogenase deficiency is an autosomal recessive disorder that affects the metabolism of short-chain fatty acids. This condition can cause symptoms such as muscle weakness, lethargy, poor feeding, and developmental delay. In severe cases, it can lead to life-threatening episodes of metabolic crisis, including hypoglycemia and liver dysfunction. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously, allowing for a more comprehensive evaluation of genetic variations. In the context of acyl-CoA short-chain dehydrogenase deficiency, NGS genetic testing can identify mutations in the ACADS gene that may be causing the condition. This type of genetic testing involves sequencing the DNA of an individual to identify any changes or variations in the ACADS gene. By identifying specific mutations in the gene, healthcare professionals can provide a more accurate diagnosis and better understand the underlying cause of the condition. NGS genetic testing can be useful for individuals with suspected acyl-CoA short-chain dehydrogenase deficiency, as it can help guide treatment decisions, provide information about the risk of passing on the condition to future children, and offer insights into potential complications or associated conditions. It is important to note that genetic testing should be performed and interpreted by qualified healthcare professionals, such as genetic counselors or medical geneticists, who can provide appropriate counseling and guidance based on the test results. |
